PRAGUE-18 Hints at Risk-Based Personalized DAPT After STEMI-PCI Discharge PRAGUE-18 Hints at Risk-Based Personalized DAPT After STEMI-PCI Discharge

Those who substituted clopidogrel for prasugrel or ticagrelor to avoid their steep out-of-pocket expense in the Czech trial, a lower-risk group as it turned out, didn ' t have more ischemic events.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Cardiology News Source Type: news